Alvotech (ALVO) Long-Term Deferred Tax (2020 - 2026)
Alvotech's (ALVO) quarterly Long-Term Deferred Tax came in at $192.9 million in Q1 2026, down 38.84% YoY from $315.3 million in Q1 2025, and little changed on a QoQ basis from $192.2 million in Q4 2025.
Alvotech (ALVO) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Long-Term Deferred Tax data on file, last reported at $192.9 million in Q1 2026.
- Quarterly Long-Term Deferred Tax fell 38.84% year-over-year to $192.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $192.9 million (down 38.84% YoY) and the FY2025 annual result came in at $192.2 million, down 35.58% from the prior year.
- Long-Term Deferred Tax steadied at $192.9 million in Q1 2026, from $192.2 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $340.5 million in Q3 2025 to a low of $188.0 million in Q2 2022.
- A 5-year average of $273.6 million and a median of $302.5 million in 2024 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax jumped 47.88% — and 2026, when it tumbled 38.84%.
- Tracing ALVO's Long-Term Deferred Tax over 5 years: stood at $209.5 million in 2022, then surged by 47.88% to $309.8 million in 2023, then slipped by 3.69% to $298.4 million in 2024, then plunged by 35.58% to $192.2 million in 2025, then grew by 0.34% to $192.9 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $192.9 million (Q1 2026), $192.2 million (Q4 2025), and $340.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192.86 Mn |
| Dec 31, 2025 | 192.21 Mn |
| Sep 30, 2025 | 340.50 Mn |
| Jun 30, 2025 | 338.33 Mn |
| Mar 31, 2025 | 315.35 Mn |
| Dec 31, 2024 | 298.36 Mn |
| Sep 30, 2024 | 320.37 Mn |
| Jun 30, 2024 | 306.64 Mn |
| Mar 31, 2024 | 318.22 Mn |
| Dec 31, 2023 | 309.81 Mn |
| Jun 30, 2023 | 260.30 Mn |
| Mar 31, 2023 | 239.71 Mn |
| Dec 31, 2022 | 209.50 Mn |
| Jun 30, 2022 | 187.98 Mn |
| Dec 31, 2021 | 170.42 Mn |
| Dec 31, 2020 | 121.86 Mn |